Essays about: "thesis on pharmaceutical patent"
Showing result 1 - 5 of 35 essays containing the words thesis on pharmaceutical patent.
-
1. Reverse Payment Patent Settlements as Restrictions by Object under Article 101(1) TFEU
University essay from Lunds universitet/Juridiska institutionen; Lunds universitet/Juridiska fakultetenAbstract : This thesis examines the CJEU’s case law on value transfers between originator and generic undertakings, in the context of patent settlements, to ascertain the criteria for determining when such a practice amounts to a restriction of competition by object. The thesis finds that the CJ’s rulings in Generics and Lundbeck clarifies the treatment of more straightforward RPPSs and follows established case law on restrictions by object. READ MORE
-
2. Access patented vaccines in the time of COVID-19 pandemic
University essay from Lunds universitet/Institutionen för handelsrättAbstract : This thesis aims to describe and analyze three different solutions on how to make vaccines for COVID-19 available from a patent law perspective under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Under the TRIPS, patent law provides exclusive rights for vaccine inventors to prevent or stop others from commercially exploiting the patented invention for 20 years. READ MORE
-
3. Patents And Human Rights : Conflicts with Access to Medicine in Pandemics, and COVID-19 Recommendations
University essay from Stockholms universitet/Juridiska institutionenAbstract : Since the last century, many wars and violations of Human Rights were direct reasons that set the pace to develop Human Rights laws, especially after the end of World War II and the holocausts associated with it. One of the critical Human Rights is that ‘to life’, relating to the right ‘to health’, hence the fundamental accessibility to healthcare services and products. READ MORE
-
4. Collaborative Drug Discovery with Blockchain Technology
University essay from Lunds universitet/Institutionen för elektro- och informationsteknikAbstract : The cost of developing and researching novel molecular compounds in the pharmaceutical industry is very high today. If an actor accidentally releases too much information about a novel molecule to the public the molecule becomes prior art, and as an effect, can not be patented. READ MORE
-
5. Protection of Traditional Medical Knowledge in the Patent System: Is There Room?
University essay from Uppsala universitet/Juridiska institutionenAbstract : Traditional knowledge (TK) is a vital component of the lives and wellbeing of many traditional communities or groups worldwide. The value of TK extends to numerous aspects of life including the health sector. In Africa, up to 80% of the population use traditional medicine or employ medicinal use of indigenous plants. READ MORE